| Name | Title | Contact Details |
|---|
Halberd Corporation has acquired exclusive licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and Cerebrospinal Fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other virus`. The issued patents` extracorporeal technology is applicable to a significant number of the most debilitating and often fatal illnesses affecting mankind: PTSD, CTE (Chronic Traumatic Encephalopathy) and Cancer, among others. We have developed an aggressive timetable to advance the development of these breakthrough technologies through laboratory, hospital, and clinical trials. In addition, we have initiated the development of potential patient trial application lists. Our management team has extensive experience and contacts in the medical/pharmaceutical fields as well as a demonstrated track record of launching new business ventures in a competitive environment.
Vasomedical, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Westbury, NY. To find more information about Vasomedical, Inc., please visit www.vasomedical.com
Regenstrief Institute, Inc., an international leader in electronic medical records and health care data integration, is a medical research and development organization focused on improving quality of care, efficiency of health care delivery, and enhancing patient outcomes.
The SoClean EcoSystem of Clean™, featuring the SoClean 3 for Sleep Equipment and SoClean Air Purifier+™, works to create a clean home environment for you and your family.
A leader in benefits management since 1938, MedBen excels in finding ways to help employer groups save money on their health care coverage. Our extensive service portfolio includes third party administration, consumer-driven products and worksite wellness.